De Luca MA - Search Results

1

The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats.

Costa G, Serra M, Pintori N, Casu MA, Zanda MT, Murtas D, De Luca MA, Simola N, Fattore L. Costa G, et al. Among authors: de luca ma. Neuropharmacology. 2019 Jan;144:219-232. doi: 10.1016/j.neuropharm.2018.10.031. Epub 2018 Oct 23. Neuropharmacology. 2019. PMID: 30366005

2

Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons.

Tronci E, Simola N, Carta AR, De Luca MA, Morelli M. Tronci E, et al. Among authors: de luca ma. J Neurochem. 2006 Aug;98(4):1078-89. doi: 10.1111/j.1471-4159.2006.03943.x. Epub 2006 Jun 12. J Neurochem. 2006. PMID: 16771831 Free article.

3

Cannabinoid facilitation of behavioral and biochemical hedonic taste responses.

De Luca MA, Solinas M, Bimpisidis Z, Goldberg SR, Di Chiara G. De Luca MA, et al. Neuropharmacology. 2012 Jul;63(1):161-8. doi: 10.1016/j.neuropharm.2011.10.018. Epub 2011 Nov 2. Neuropharmacology. 2012. PMID: 22063718 Free PMC article.

4

Evidence for a role of a dopamine/5-HT6 receptor interaction in cocaine reinforcement.

Valentini V, Piras G, De Luca MA, Perra V, Bordi F, Borsini F, Frau R, Di Chiara G. Valentini V, et al. Among authors: de luca ma. Neuropharmacology. 2013 Feb;65:58-64. doi: 10.1016/j.neuropharm.2012.08.025. Epub 2012 Sep 7. Neuropharmacology. 2013. PMID: 22982249

5

Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?

De Luca MA, Cauli O, Morelli M, Simola N. De Luca MA, et al. J Neurochem. 2014 Nov;131(3):284-9. doi: 10.1111/jnc.12809. Epub 2014 Jul 30. J Neurochem. 2014. PMID: 24989117 Free article.

6

Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid.

De Luca MA, Bimpisidis Z, Melis M, Marti M, Caboni P, Valentini V, Margiani G, Pintori N, Polis I, Marsicano G, Parsons LH, Di Chiara G. De Luca MA, et al. Neuropharmacology. 2015 Dec;99:705-14. doi: 10.1016/j.neuropharm.2015.08.041. Epub 2015 Oct 23. Neuropharmacology. 2015. PMID: 26327678

7

Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135.

De Luca MA, Castelli MP, Loi B, Porcu A, Martorelli M, Miliano C, Kellett K, Davidson C, Stair JL, Schifano F, Di Chiara G. De Luca MA, et al. Neuropharmacology. 2016 Jun;105:630-638. doi: 10.1016/j.neuropharm.2015.11.017. Epub 2015 Dec 11. Neuropharmacology. 2016. PMID: 26686391

8

4,4'-Dimethylaminorex ("4,4'-DMAR"; "Serotoni") misuse: A Web-based study.

Loi B, Zloh M, De Luca MA, Pintori N, Corkery J, Schifano F. Loi B, et al. Among authors: de luca ma. Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2575. Hum Psychopharmacol. 2017. PMID: 28657180 Review.

9

Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps.

Miliano C, Margiani G, Fattore L, De Luca MA. Miliano C, et al. Among authors: de luca ma. Brain Sci. 2018 Jun 29;8(7):123. doi: 10.3390/brainsci8070123. Brain Sci. 2018. PMID: 29966280 Free PMC article. Review.

10

Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?

De Luca MA, Fattore L. De Luca MA, et al. Clin Ther. 2018 Sep;40(9):1457-1466. doi: 10.1016/j.clinthera.2018.08.002. Epub 2018 Sep 1. Clin Ther. 2018. PMID: 30180974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters